Olaplex (OLPX) director receives 110,294 RSUs vesting at 2026 annual meeting

Rhea-AI Filing Summary

Martha A. Morfitt, a director of Olaplex Holdings, Inc. (OLPX), was granted 110,294 restricted stock units (RSUs) on 08/12/2025. Each RSU converts to one share of common stock and the grant was reported with a $0 price. After the award the reporting person beneficially owned 402,833 shares directly and the reporting person’s spouse beneficially owned 9,000 shares indirectly. The RSUs will vest in full on the date of the issuer’s 2026 Annual Meeting of Stockholders, conditioned on the reporting person’s continued service through that date. The Form 4 was signed by attorney-in-fact John Duffy on 08/14/2025.

Positive

• Director received 110,294 RSUs, increasing reported beneficial ownership and aligning executive incentives with shareholders
• RSUs vest in full on the 2026 Annual Meeting date, promoting retention through the next annual cycle
• Reporting shows direct and indirect holdings (402,833 direct; 9,000 indirect via spouse), improving transparency

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received a material RSU grant that vests at the 2026 annual meeting, increasing insider alignment with shareholders.

The grant of 110,294 RSUs to a director is a meaningful equity compensation event that increases the director’s reported beneficial ownership to 402,833 shares. Time-based vesting to the 2026 annual meeting ties retention to continued service and aligns the director’s economic interest with long-term shareholder outcomes. The $0 reported price reflects that these are restricted awards rather than an open-market purchase. No derivative transactions or sales were reported in this filing.

Securities Analyst

TL;DR: This Form 4 discloses a standard director RSU grant; it raises insider ownership but contains no liquidity or disposition events.

The filing documents an acquisition (grant) of RSUs rather than a purchase, which does not immediately change free-float but increases potential future dilution when RSUs settle into shares. Vesting is time-based and contingent on continued service through the 2026 Annual Meeting. The filing includes an indirect holding of 9,000 shares by the spouse, which should be aggregated for beneficial-ownership considerations. No exercised options, sales, or derivative movements are present in this report.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MORFITT MARTHA A M

(Last) (First) (Middle)

C/O OLAPLEX HOLDINGS, INC.

432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		A		110,294(1)	A	$0	402,833	D
Common Stock								9,000	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Remarks:

	/s/ John Duffy, attorney-in-fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Martha A. Morfitt report on Form 4 for OLPX?

The Form 4 reports a grant of 110,294 restricted stock units (RSUs) to Martha A. Morfitt on 08/12/2025; after the grant she beneficially owned 402,833 shares directly.

When do the RSUs granted to the OLPX director vest?

The RSUs will vest in full on the date of Olaplex Holdings' 2026 Annual Meeting of Stockholders, subject to the reporting person’s continued service through that date.

What is the reported price for the RSU grant in the OLPX Form 4?

The grant is reported with a price of $0, indicating these are restricted awards rather than an open-market purchase.

Does the Form 4 show any dispositions or exercises by the director?

No. The filing shows an acquisition (grant) of RSUs and does not report any sales, exercises, or derivative transactions.

Who signed the Form 4 for Martha Morfitt and when was it signed?

The Form 4 was signed by attorney-in-fact John Duffy on 08/14/2025.